Jantoven is used to treat and prevent venous thrombosis and pulmonary embolism. It is also prescribed to treat and prevent thromboembolic complications associated with atrial fibrillation and cardiac valve replacement. Jantoven is indicated for reducing the risk of death, recurrent myocardial infarction, and thromboembolic events like stroke.
Full prescribing information is available at:
http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=6203
